Nephrocare Health IPO Shows Exceptional Demand, Subscribed 14.06x on Day 3

Nephrocare Health Services Limited's initial public offering (IPO) has demonstrated exceptional investor interest through its third day of subscription. The stock price band is set at ₹438-460 per share. The ₹871.05 crore IPO reached 14.06 times by 4:54:35 PM on day three. This indicates exceptional investor interest in India's and Asia's largest dialysis chain, incorporated in 2010.

Nephrocare Health IPO subscription reached exceptional 14.06 times on day three. It was led by Qualified Institutional Buyers Ex-Anchor (26.82x), Non-Institutional Investors (24.75x), Employees (2.80x), and Retail Investors (2.33x). Total applications reached 4,48,502.

Invest in Indian Markets and Unlock Future Potential With 5paisa!

Open Account Now

Subscription Status of Nephrocare Health IPO:

Here are the subscription details for Nephrocare Health IPO as of Day 3 (December 12, 2025, 4:54:35 PM):

Key Highlights - Day 3:

• Overall subscription reached exceptional 14.06 times, showing extraordinary improvement from day two's 0.37 times
• Employee category showing moderate performance at 2.80 times, building substantially from day two's 1.26 times, indicating improved employee sentiment with ₹41 discount offered
• Retail investors displaying moderate confidence at 2.33 times, building substantially from day two's 0.47 times, indicating improved retail demand
• Total applications reached 4,48,502, showing exceptional investor participation for this mainboard IPO, a significant increase from day two's 73,120 applications
• Cumulative bid amount reached ₹8,585.75 crores, significantly exceeding the net offer size of ₹610.79 crores (excluding anchor portion) by over 14 times
• Anchor investors fully subscribed their allocation of ₹260.26 crores on December 9, 2025
• Employee discount of ₹41 per share offered on the issue price

Key Highlights - Day 2:

• Overall subscription reached weak 0.37 times, showing substantial improvement from day one's 0.13 times but still indicating subdued investor interest
• Retail investors displaying weak confidence at 0.47 times, building substantially from day one's 0.21 times
• Employee category showing moderate performance at 1.26 times, building substantially from day one's 0.60 times
• Qualified institutional buyers showing weak participation at 0.29 times, improving from day one's 0.00 times
• Non-institutional investors showing weak performance at 0.23 times, marginally improving from day one's 0.10 times

Key Highlights - Day 1:

• Overall subscription reached weak 0.13 times, showing very cautious initial investor interest
• Employee category displaying weak confidence at 0.60 times, indicating subdued employee sentiment
• Retail investors showing weak participation at 0.21 times, indicating very weak retail appetite
• Non-institutional investors showing negligible performance at 0.10 times, indicating very weak HNI interest
• Qualified institutional buyers showing negligible participation at 0.00 times, indicating virtually no institutional interest

About Nephrocare Health Services Limited

Incorporated in 2010, Nephrocare Health Services Limited provides end-to-end dialysis care through a wide network of clinics across India and select international markets. The company offers services including diagnosis, haemodialysis, home and mobile dialysis, and wellness programs, supported by an in-house pharmacy. As of September 30, 2025, Nephrocare operated 519 clinics with 51 across the Philippines, Uzbekistan, and Nepal, including the world's largest dialysis clinic in Uzbekistan.